HilleVax
Acquired6 known investors
Find your way into HilleVax
XOMA Royalty is a biotech royalty aggregator that acquires the economic rights to future milestone and royalty payments tied to partnered pre-commercial clinical candidates, providing sellers with non-dilutive, non-recourse funding. It holds a portfolio of 120+ assets and serves biotech companies developing drug candidates.
Investors · 6
In the news
Frequently asked questions
- What does HilleVax do?
- XOMA Royalty is a biotech royalty aggregator that acquires the economic rights to future milestone and royalty payments tied to partnered pre-commercial clinical candidates, providing sellers with non-dilutive, non-recourse funding. It holds a portfolio of 120+ assets and serves biotech companies developing drug candidates.
- Who are HilleVax's investors?
- HilleVax's investors include Catalys Pacific, Frazier Life Sciences, Lightspeed Venture Partners, RA Capital, Samsara BioCapital, Frazier Healthcare Partners.